Breast Cancer: Current Research
Open Access

Cynthia Xiuguang Ma

Biography

Dr. Cynthia Ma obtained her MD from Beijing Medical University in China and subsequently PhD in Developmental Biology from the University of Cincinnati. She completed her Internal Medicine residency from New Hanover Regional Medical Center in North Carolina followed by the Hematology/Medical Oncology fellowship at Mayo Clinic, Rochester, Minnesota. In 2005, she was recruited as a breast oncologist at Washington University School of Medicine (WUSM). She is currently an Associate Professor of Medicine and a research member of Siteman Cancer Center. In August 2014, Dr. Ma was appointed as the Clinical Director of the Breast Cancer Program, Section of Medical Oncology, Division of Oncology at WUSM. Dr. Ma’s research includes preclinical and clinical trial development of molecularly targeted cancer therapeutics for the treatment of resistant breast cancer. She is the principal investigator for several biomarker directed clinical trials of biological agents including UCN-01, temsirolimus, MK2206, BKM120, IMC-A12, and palbociclib in breast cancer.

Research Interest

Identification of predictive genetic markers in the treatment of breast cancer, especially with hormonal and other targeted therapies, pharmacogenomics, phase I and II clinical trials to develop novel therapeutic agents for the treatment of solid tumors, especially breast cancer